Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.
Health
In the 2022/2023 business year, the company’s product portfolio consisted of 653 products
Egis changes the secondary packaging design of Suprastin®
Egis informs about the secondary packaging changes of Suprastin®in tablet forms manufactured by Egis Pharmaceuticals PLC" (Hungary). The secondary packaging receives a new color scheme and visual cues that make the pharmaceutical product more visible in the particular category and more convinient for consumers. At the same time, the composition of the product and its properties remain unchanged.
Zalagel® Intim: a novelty for daily care of female intimate health
EGIS-RUS announces the expansion of its Women’s health portfolio by a new brand under Zalain product line. It will be replenished with the new Zalagel® Intim moisturizing gel for intimate hygiene with a unique combination of tea tree oil and weakly alkaline pH 8-9.
D-Pantenol Novatenol - a new brand name of a well-known drug from the European manufacturer
EGIS-RUS LLC made rebranding of the popular skin repair products: D-Panthenol Novatenol (cream and ointment) took place D-Panthenol (cream and ointment) on pharmacy shelves.
Egis changed design of its products packages
We inform our customers, partners and consumers about the change packaging design of more than 30 products.
Other channels
Egis' products are sold to 100 countries.
Our mission is to serve people with all of our skills, ensuring that they live a long and healthy life
In the 2022/2023 business year, we spent EUR 48 million on research and development
Healthcare and sharing knowledge are in the heart of our CSR activities
Our highlighted past and future events you shouldn't miss
Quick news
Your browser is out of date. Please, use an updated version!